πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 980 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8193352

Gyrase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jun 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8193194

Ion channel modulators and methods of use

Vertex Pharmaceuticals Incorporated Β· Granted Tue Jun 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8188095

Gyrase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated Β· Granted Tue May 29 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8188283

Modulators of cystic fibrosis transmembrane conductance regulator

Vertex Pharmaceuticals Incorporated Β· Granted Tue May 29 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8188281

Azaindoles useful as inhibitors of JAK and other protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue May 29 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8188134

Thiophene-carboxamides useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue May 29 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8188071

Amino substituted pyridines as potent kinase inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue May 29 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8187874

Drug discovery method

Vertex Pharmaceuticals Incorporated Β· Granted Tue May 29 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8173635

Kinase inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8168798

Caspase inhibitor prodrugs

Vertex Pharmaceuticals Incorporated Β· Granted Tue May 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8163917

Azaindoles useful as inhibitors of Janus kinases

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8163772

Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxypheny1]-1,4-dihydro-4-oxoquinoline-3

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8163720

Pyrrolidinyl phenyl sulphonamides as modulators of ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8163737

CGRP receptor antagonists

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8163732

Tricyclic heteroaryl compounds useful as inhibitors of Janus kinase

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8158637

Quinazolines useful as modulators of voltage gated ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 17 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8153642

Quinazolines useful as modulators of ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8153668

Polymorphic forms of (S)-1-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl)phenyl)urei

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8153655

Compositions useful as inhibitors of voltage-gated sodium channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8143297

Heterocyclic derivatives as modulators of ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8129387

Substituted 5,6-dihydroimidazo[1,5-F]pteridines useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8129546

Derivatives for modulation of ion channels

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8129399

Aminopyrimidines useful as kinase inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8129381

Caspase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated Β· Granted Tue Mar 06 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted